Stripe, Anthropic and OpenAI are backing an effort to stop respiratory infections

Stripe, alongside AI firms Anthropic and OpenAI, is investing in a groundbreaking initiative aimed at tackling respiratory infections, including the common cold. The focus is on leveraging advanced technology to develop new prevention and treatment methods, potentially revolutionizing how we handle these ubiquitous ailments. This move underscores the growing intersection of tech innovation and healthcare, highlighting the potential for AI and data-driven approaches to make significant strides in medical science. By backing this effort, these companies are positioning themselves at the forefront of a transformative wave in disease prevention.